243 related articles for article (PubMed ID: 23516367)
1. The HPV16 E6 oncoprotein causes prolonged receptor protein tyrosine kinase signaling and enhances internalization of phosphorylated receptor species.
Spangle JM; Munger K
PLoS Pathog; 2013 Mar; 9(3):e1003237. PubMed ID: 23516367
[TBL] [Abstract][Full Text] [Related]
2. The human papillomavirus type 16 E6 oncoprotein activates mTORC1 signaling and increases protein synthesis.
Spangle JM; Münger K
J Virol; 2010 Sep; 84(18):9398-407. PubMed ID: 20631133
[TBL] [Abstract][Full Text] [Related]
3. Cytoplasmic poly(A) binding proteins regulate telomerase activity and cell growth in human papillomavirus type 16 E6-expressing keratinocytes.
Katzenellenbogen RA; Vliet-Gregg P; Xu M; Galloway DA
J Virol; 2010 Dec; 84(24):12934-44. PubMed ID: 20943973
[TBL] [Abstract][Full Text] [Related]
4. The Human Papillomavirus 16 E7 Oncoprotein Attenuates AKT Signaling To Promote Internal Ribosome Entry Site-Dependent Translation and Expression of c-MYC.
Strickland SW; Vande Pol S
J Virol; 2016 Jun; 90(12):5611-5621. PubMed ID: 27030265
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of the epidermal growth factor receptor by erlotinib prevents immortalization of human cervical cells by Human Papillomavirus type 16.
Woodworth CD; Diefendorf LP; Jette DF; Mohammed A; Moses MA; Searleman SA; Stevens DA; Wilton KM; Mondal S
Virology; 2011 Dec; 421(1):19-27. PubMed ID: 21982220
[TBL] [Abstract][Full Text] [Related]
6. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
McFarlane M; MacDonald AI; Stevenson A; Graham SV
J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
[TBL] [Abstract][Full Text] [Related]
7. E6 Protein Expressed by High-Risk HPV Activates Super-Enhancers of the
Chen X; Loo JX; Shi X; Xiong W; Guo Y; Ke H; Yang M; Jiang Y; Xia S; Zhao M; Zhong S; He C; Fu L; Li F
Cancer Res; 2018 Mar; 78(6):1418-1430. PubMed ID: 29339538
[TBL] [Abstract][Full Text] [Related]
8. IRF-1 Inhibits Angiogenic Activity of HPV16 E6 Oncoprotein in Cervical Cancer.
Rho SB; Lee SH; Byun HJ; Kim BR; Lee CH
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33076322
[TBL] [Abstract][Full Text] [Related]
9. Activation of cap-dependent translation by mucosal human papillomavirus E6 proteins is dependent on the integrity of the LXXLL binding motif.
Spangle JM; Ghosh-Choudhury N; Munger K
J Virol; 2012 Jul; 86(14):7466-72. PubMed ID: 22553330
[TBL] [Abstract][Full Text] [Related]
10. HPV16 E6 promotes cervical cancer cell migration and invasion by downregulation of NHERF1.
Wang Q; Song R; Zhao C; Liu H; Yang Y; Gu S; Feng D; He J
Int J Cancer; 2019 Apr; 144(7):1619-1632. PubMed ID: 30230542
[TBL] [Abstract][Full Text] [Related]
11. ErbB2/HER2 receptor tyrosine kinase regulates human papillomavirus promoter activity.
Mikuličić S; Shamun M; Massenberg A; Franke AL; Freitag K; Döring T; Strunk J; Tenzer S; Lang T; Florin L
Front Immunol; 2024; 15():1335302. PubMed ID: 38370412
[TBL] [Abstract][Full Text] [Related]
12. PDZ Domain-Containing Protein NHERF-2 Is a Novel Target of Human Papillomavirus 16 (HPV-16) and HPV-18.
Saidu NEB; Filić V; Thomas M; Sarabia-Vega V; Đukić A; Miljković F; Banks L; Tomaić V
J Virol; 2019 Dec; 94(1):. PubMed ID: 31597772
[TBL] [Abstract][Full Text] [Related]
13. Detection of human papillomavirus in human focal cortical dysplasia type IIB.
Chen J; Tsai V; Parker WE; Aronica E; Baybis M; Crino PB
Ann Neurol; 2012 Dec; 72(6):881-92. PubMed ID: 23280839
[TBL] [Abstract][Full Text] [Related]
14. Two common variants of human papillomavirus type 16 E6 differentially deregulate sugar metabolism and hypoxia signalling in permissive human keratinocytes.
Cuninghame S; Jackson R; Lees SJ; Zehbe I
J Gen Virol; 2017 Sep; 98(9):2310-2319. PubMed ID: 28857035
[TBL] [Abstract][Full Text] [Related]
15. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3.
Yin F; Wang N; Wang S; Yu F; Sun X; Yu X; Luo B; Zhao C; Wang Y
Oncol Rep; 2017 Apr; 37(4):2324-2334. PubMed ID: 28260046
[TBL] [Abstract][Full Text] [Related]
16. Cellular entry of human papillomavirus type 16 involves activation of the phosphatidylinositol 3-kinase/Akt/mTOR pathway and inhibition of autophagy.
Surviladze Z; Sterk RT; DeHaro SA; Ozbun MA
J Virol; 2013 Mar; 87(5):2508-17. PubMed ID: 23255786
[TBL] [Abstract][Full Text] [Related]
17. A transcriptomic landscape of human papillomavirus 16 E6-regulated gene expression and splicing events.
Xu J; Fang Y; Qin J; Chen X; Liang X; Xie X; Lu W
FEBS Lett; 2016 Dec; 590(24):4594-4605. PubMed ID: 27859058
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of HPV16 E6* Alters β-Integrin and Mitochondrial Dysfunction Pathways in Cervical Cancer Cells.
Evans W; Filippova M; Filippov V; Bashkirova S; Zhang G; Reeves ME; Duerksen-Hughes P
Cancer Genomics Proteomics; 2016; 13(4):259-73. PubMed ID: 27365376
[TBL] [Abstract][Full Text] [Related]
19. HPV type 16 E6 and NFX1-123 augment JNK signaling to mediate keratinocyte differentiation and L1 expression.
Levan J; Vliet-Gregg PA; Robinson KL; Matsumoto LR; Katzenellenbogen RA
Virology; 2019 May; 531():171-182. PubMed ID: 30903928
[TBL] [Abstract][Full Text] [Related]
20. Hyaluronan-CD44 interaction promotes HPV 16 E6 oncogene-mediated oropharyngeal cell carcinoma survival and chemoresistance.
Bourguignon LYW; Earle C; Shiina M
Matrix Biol; 2019 May; 78-79():180-200. PubMed ID: 30077625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]